Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Commentary|Slideshows|May 15, 2024
HRSA Women's Preventive Health Services Guidelines: A Topline Look
Author(s)Kenneth Bender, PharmD, MA
Get a quick overview of recommendations for preventive health services and screenings focused on the unique needs of women across the lifespan.
Advertisement
The Health Resources & Services Administration (HRSA)-supported Women's Preventive Services
The guideline topline that follows summarizes the most recent iteration of the Guidelines for a quick, at-a-glance review.
Advertisement
Related to this article
The FDA accepted Bayer's sNDA and granted Priority Review to elinzanetant for vasomotor symptoms in women on endocrine therapy for HR+ breast cancer.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
Real-world phase 4 data show fezolinetant eases menopausal hot flashes and improves sleep, cutting nighttime awakenings by 2.6 by week 12.
The FDA accepted Organon’s MIUDELLA supplemental application, but the proposed change, supporting data, and review timeline remain undisclosed.
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Advertisement
Advertisement
Trending on Patient Care Online
1
Abbott Gains FDA Approval for CardioMEMS Update Letting Heart Failure Patients View Pressure Readings on Their Phones
2
FDA Approves Once-Monthly Olanzapine Injection for Adults With Schizophrenia
3
9 Drugs Approved for Primary Care: Q3 2026
4
Multicomponent Strategies to Ease Vaccination Pain and Fear Across Ages
5